CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
TOTAL REVENUE	$ 10,113	$ 3,748
COST OF GOODS SOLD	(8,180)	(2,602)
RESEARCH AND DEVELOPMENT EXPENSES	(3,475)	(2,887)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	(2,603)	(3,115)
OPERATING LOSS	(4,145)	(4,856)
FINANCIAL EXPENSES	(6)	(390)
FINANCIAL INCOME	419	513
FINANCIAL INCOME, NET	413	123
LOSS BEFORE TAXES ON INCOME	(3,732)	(4,733)
TAX BENEFIT	113	138
NET LOSS	$ (3,619)	$ (4,595)
LOSS PER SHARE OF COMMON STOCK - BASIC (in dollars per share)	$ (0.05)	$ (0.06)
LOSS PER SHARE OF COMMON STOCK - DILUTED (in dollars per share)	$ (0.05)	$ (0.06)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - BASIC (in shares)	76,611,980	73,036,569
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - DILUTED (in shares)	76,611,980	73,036,569
Goods
TOTAL REVENUE	$ 9,995	$ 3,677
License and R&D Services
TOTAL REVENUE	$ 118	$ 71